BRAND REFERENCE
Saxenda®, Victoza®, Trulicity® and Byetta® — The Earlier GLP-1 Medicines
Before semaglutide and tirzepatide there was an earlier generation of GLP-1 medicines. Their names are still widely searched — this is what they are.
WHAT WE DO NOT SUPPLY
We do not sell Saxenda®, Victoza®, Trulicity®, Byetta®, liraglutide, dulaglutide or exenatide, and we are not a pharmacy. Our compounds are for laboratory research use only — not medicines, and not for human or veterinary use.
LIVING WATER LABS · RESEARCH-GRADE
Research-grade GLP compounds from LWL
Live price and stock. Lyophilised research vials, Janoshik HPLC purity certificates, dispatched from Johannesburg. For laboratory research use only.
From the newer end of the incretin field, LWL supplies research-grade tirzepatide (dual agonist), retatrutide (triple agonist) and eloralintide (amylin agonist) for laboratory research.

Retatrutide 30mg
GLP-1 / GIP / glucagon receptor triple agonist
VIEW RESEARCH COMPOUND →

Retatrutide 60mg
GLP-1 / GIP / glucagon receptor triple agonist
VIEW RESEARCH COMPOUND →

Tirzepatide 30mg
GIP / GLP-1 receptor dual agonist
VIEW RESEARCH COMPOUND →

Tirzepatide 60mg
GIP / GLP-1 receptor dual agonist
VIEW RESEARCH COMPOUND →

Eloralintide
Selective amylin receptor agonist
VIEW RESEARCH COMPOUND →
Retatrutide certificate summary →Tirzepatide certificate summary →
Exenatide (Byetta®) was the first GLP-1 receptor agonist medicine, derived from a peptide found in Gila monster saliva and given twice daily. Liraglutide followed as a once-daily injection — Victoza® and Saxenda® are two Novo Nordisk brands of it at different strengths for different approved uses. Dulaglutide (Trulicity®, Eli Lilly) moved the class to once-weekly dosing by fusing the peptide to a larger protein to extend its half-life.
The direction of travel since then has been longer action and more receptors: semaglutide refined the single-receptor GLP-1 agonist, tirzepatide added the GIP receptor, and molecules such as retatrutide add the glucagon receptor as well. Each of these is a distinct molecule, not a newer version of the same product.
All the medicines named on this page are registered prescription products. We sell none of them. What we supply are research-grade compounds from the newer end of the field — tirzepatide, retatrutide and eloralintide — for laboratory research.
Side by side
Byetta®
Exenatide · twice-daily injection
Not stocked
Victoza® / Saxenda®
Liraglutide · once-daily injection (Novo Nordisk)
Not stocked
Trulicity®
Dulaglutide · once-weekly injection (Eli Lilly)
Not stocked
Newer research molecules
—
Tirzepatide, retatrutide, eloralintide research vials
LWL research GLP compounds compared
Receptor pharmacology, vial size and price per milligram — live. Pre-order prices include the 10% pre-order saving. Research use only.
| Compound | Receptor targets | Vial | Price | Per mg | Status |
|---|---|---|---|---|---|
| Retatrutide 30mgLY3437943 | GLP-1 / GIP / glucagon receptor triple agonist | 30 mg | R1,574 | R52.5/mg | PRE-ORDER · SHIPS 15 OCT · 10% OFF |
| Retatrutide 60mgLY3437943 | GLP-1 / GIP / glucagon receptor triple agonist | 60 mg | R3,399 | R56.6/mg | IN STOCK · SAME-DAY DISPATCH |
| Tirzepatide 30mgLY3298176 | GIP / GLP-1 receptor dual agonist | 30 mg | R1,259 | R42.0/mg | PRE-ORDER · SHIPS 15 OCT · 10% OFF |
| Tirzepatide 60mgLY3298176 | GIP / GLP-1 receptor dual agonist | 60 mg | R2,429 | R40.5/mg | PRE-ORDER · SHIPS 15 OCT · 10% OFF |
| EloralintideLY3841136 | Selective amylin receptor agonist | 15 mg | R2,699 | R180/mg | PRE-ORDER · SHIPS 15 OCT · 10% OFF |
Also searched as
These are the short forms, spellings and code designations people use for the same thing. They are listed so the terminology is unambiguous, not because any of them names a different product.
Questions
Do you sell Saxenda® or liraglutide?
No. Saxenda® and Victoza® are Novo Nordisk medicines containing liraglutide. We do not stock liraglutide in any form.
How is liraglutide different from semaglutide?
Both are GLP-1 receptor agonists, but they are different molecules with different durations of action — liraglutide is given daily, semaglutide weekly.
What do you supply?
Research-grade tirzepatide, retatrutide and eloralintide vials, for laboratory research only. Not medicines, and not for human or veterinary use.
CONTINUE TO THE RESEARCH COMPOUNDS
Read next
Every compound we supply is sold strictly for laboratory research purposes only. Not for human or veterinary use, and not a medicine. Nothing on this page is medical advice, a dosing instruction or a claim of any outcome.
Saxenda® and Victoza® are registered trademarks of Novo Nordisk A/S. Trulicity® is a registered trademark of Eli Lilly and Company. Byetta® is a registered trademark of its respective owner. Living Water Labs is not affiliated with, endorsed by or connected to any of these companies, and does not supply any of these medicines. The names are used here only to identify what they are.